Prognostic value of PD-L1 expression in combination with CD8+TILs density in patients with surgically resected non-small cell lung cancer-Reference-Cited by-全球学者库

Prognostic value of PD-L1 expression in combination with CD8+TILs density in patients with surgically resected non-small cell lung cancer

Published:2017-11-23 Issue:1 Volume:7 Page:32-45
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Yang Hui¹,Shi Jinpeng¹,Lin Dongmei²,Li Xuefei³,Zhao Chao³,Wang Qi⁴,Zhang Limin¹^ORCID,Jiang Tao¹,Zhao Sha¹,Liu Xiaozhen¹,Jia Yijun¹,Zhang Yajun⁵,Cai Weijing¹,Zhou Caicun¹^ORCID

Affiliation:

1. Department of Medical Oncology; Shanghai Pulmonary Hospital & Thoracic Cancer Institute; Tongji University School of Medicine; Shanghai 200433 China

2. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education); Peking University Cancer Hospital and Institute; Beijing 100142 China

3. Department of Lung Cancer and Immunology; Shanghai Pulmonary Hospital & Thoracic Cancer Institute; Tongji University School of Medicine; Shanghai 200433 China

4. Department of Pathology; Yancheng Third People's Hospital; Yancheng 224001 China

5. Department of Thoracic Surgery; Yancheng Third People's Hospital; Yancheng 224001 China

Funder

National Natural Science Foundation of China

Science and Technology Commission of Shanghai Municipality

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Reference44 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J. Clin.,2015

2. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer;Reck;N. Engl. J. Med.,2016